“If you would like to get the latest updates on HeartBeat.bio please refer to our press releases or partner news below or follow us onLinkedInor Twitter. “
Outreach activities
August 2022
Join this virtual panel discussion to identify ways to overcome common challenges in 3D biology research, regardless of where you are in your journey.
Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid that mirrors the heart’s intricate structure enables scientists to advance screening platforms for drug development, toxicology studies, and understanding heart development. The...
Vienna, Austria – 02 November 2023 – HeartBeat.bio AG, a biotech company building a highly scalable human organoid and AI-supported drug discovery platform for heart disease, today announced the closing of a € 4.5 million Pre-Series A round co-led by i&i Biotech Fund, Invest AG, aws Gründungsfonds II, and Tensor Ventures....
VIENNA, Austria – 5 October 2022 – HeartBeat.bio AG has entered a collaboration with Boehringer Ingelheim for the investigation of human cardiac organoids (Cardioids) for high-throughput early safety assessment and drug discovery.
VIENNA and SAN JOSE, CA – Sept. 12 – HeartBeat.bio AG, a biotech company developing cardiac organoids (Cardioids) for drug discovery, and Molecular Devices, LLC., a leading provider of high-performance life science solutions, have entered into a co-development agreement...
scientific publications
Cell, November 2023
Multi-chamber cardioids unravel human heart development and cardiac defects
Discover 20 Innovative Pharma Startups to Watch (2024) Looking for the latest emerging technologies impacting pharmaceuticals? Explore the innovative solutions from 20 hand-picked Pharma Startups to Watch in 2024 working on accelerated drug discovery, targeted cancer therapeutics, non-destructive live cell analysis, and more!
Verantwortung übernehmen, nachhaltig investieren Als der führende Private-Equity-Fonds in Österreich ist sich die Invest AG ihrer großen Verantwortung gegenüber dem heimischen Standort und einer nachhaltigen Zukunft bewusst.
Global Startup Heat Map highlights 10 Pharma Startups to Watch in 2023 Through the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform...
In Laborschalen wachsen Herzkammern im Miniformat. Die Technik bildet menschliche Organe nach und kann in der Forschung den Einsatz von Tierexperimenten verringern.
